Aldren 70

Aldren 70

alendronic acid

Manufacturer:

Cadila Healthcare

Distributor:

Metro Drug

Marketer:

Zydus Healthcare Phils
Concise Prescribing Info
Contents
Alendronate Na
Indications/Uses
Treatment & prevention of osteoporosis in postmenopausal women. Treatment to increase bone mass in men w/ osteoporosis.
Dosage/Direction for Use
70 mg once wkly.
Administration
Should be taken on an empty stomach: Take at least 30 min before the 1st food/drink/medication of the day w/ a full glass of plain water & remain in sitting/upright position for at least 30 min. Swallow whole, do not chew/crush.
Contraindications
Hypersensitivity. Abnormalities of the esophagus which delay esophageal emptying eg, stricture or achalasia. Inability to stand or sit upright for at least 30 min. Hypocalcemia.
Special Precautions
Discontinue use if dysphagia, odynophagia, retrosternal pain or new or worsening heartburn develop. Patients w/ active upper GI problems eg, dysphagia, esophageal diseases, gastritis, duodenitis or ulcers. Correct hypocalcemia & treat other disturbances of mineral metabolism (eg, vit D deficiency) prior to initiating therapy. Renal insufficiency (CrCl <35 mL/min). Pregnancy & lactation. Childn.
Adverse Reactions
Abdominal pain, nausea, dyspepsia, constipation, diarrhea, flatulence, acid regurgitation, esophageal ulcer, vomiting, dysphagia, abdominal distension, gastritis, gastric ulcer, melena; musculoskeletal (bone, muscle or joint) pain, muscle cramps; headache, dizziness; taste perversion.
Drug Interactions
Ca supplements, antacids; aspirin-containing products; NSAIDs; IV ranitidine.
ATC Classification
M05BA04 - alendronic acid ; Belongs to the class of bisphosphonates. Used in the treatment of bone diseases.
Presentation/Packing
Form
Aldren tab 70 mg
Packing/Price
4's (P210/tab)
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Sign up for free
Already a member? Sign in